Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria Reply

被引：14

作者：

Simoens, Steven ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Res Ctr Pharmaceut Care & Pharmacoecon, Fac Pharmaceut Sci, B-3000 Louvain, Belgium

来源：

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH | 2010年 / 7卷 / 04期

关键词：

health economics; economic evaluation; cost-effectiveness; cost-effectiveness threshold; opportunity cost; decision criteria; multi-criteria decision analysis; CARE;

D O I：

10.3390/ijerph7041835

中图分类号：

X [环境科学、安全科学];

学科分类号：

08 ; 0830 ;

摘要：

An article published in this Journal argued that New Zealand does not apply a cost-effectiveness threshold because medicines are funded within a fixed budget and because cost-effectiveness is only one of nine criteria that inform decisions. This Comment has explained that, from a theoretical perspective, the cost-effectiveness threshold model is not inconsistent with these two arguments. The observed annual variation in incremental cost-effectiveness ratios in New Zealand may originate from yearly differences in new medicines that request reimbursement and in the budget size, and from the fact that decision makers take into account other decision criteria in addition to cost-effectiveness.

引用

页码：1835 / 1840

页数：6

共 10 条

[1] Priority setting of health interventions: The need for multi-criteria decision analysis [J].